Lixte Biotechnology Holdings, Inc. Share Price
Equities
LIXT
US5393193017
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.26 USD | +1.24% | -5.92% | +38.72% |
23/04 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
27/03 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.29M 441M |
---|---|---|---|---|---|
Net income 2022 | -6M -500M | Net income 2023 | -5M -417M | EV / Sales 2022 | - |
Net cash position 2022 | 5.35M 446M | Net cash position 2023 | 4.2M 350M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.28
x | P/E ratio 2023 |
-0.88
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.81% |
1 day | +1.24% | ||
1 week | -5.92% | ||
Current month | -3.55% | ||
1 month | +44.57% | ||
3 months | +63.82% | ||
6 months | +35.27% | ||
Current year | +38.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 17/22/17 | |
Director of Finance/CFO | 72 | 12/20/12 | |
Eric Forman
COO | Chief Operating Officer | 44 | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
René Bernards
BRD | Director/Board Member | 72 | 15/22/15 |
Chief Executive Officer | 52 | 17/22/17 | |
Yun Yen
BRD | Director/Board Member | 70 | 04/18/04 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 3.26 | +1.24% | 4,162 |
25/24/25 | 3.22 | -1.83% | 14,871 |
24/24/24 | 3.28 | +1.86% | 16,082 |
23/24/23 | 3.22 | -3.88% | 40,469 |
22/24/22 | 3.35 | -3.32% | 21,756 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+38.72% | 7.33M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- LIXT Stock